[Federal Register Volume 84, Number 207 (Friday, October 25, 2019)]
[Notices]
[Pages 57435-57437]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-23366]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-20-1158; Docket No. CDC-2019-0095]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled CDC Ideation Catalyst (I-
Catalyst) Program and Customer Engagement Information Collection. CDC
will collect qualitative information from potential customers and other
stakeholders about their needs and preferred approaches to solving
public health problems. Findings will be used to improve customer
satisfaction with, and usability of, CDC's products, programs, and
services.
DATES: CDC must receive written comments on or before December 24,
2019.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0095 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without
[[Page 57436]]
change, all relevant comments to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
CDC Ideation Catalyst (I-Catalyst) Program and Customer Engagement
Information Collection (OMB Control No. 0920-1158, Exp. 1/31/2020)--
Revision--Office of Science (OS), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The CDC Office of Technology and Innovation (OTI) within Office of
Science (OS) fosters innovative science and promotes the testing and
implementation of innovative ideas that improve CDC's ability to have
public health impact. To arm CDC staff with an expanded skill-set and
tools to evaluate and translate their insights and ideas into
solutions, CDC developed an experiential innovation curriculum called
Ideation Catalyst (I-Catalyst). The program was created with the belief
that innovation should be customer-driven, be based on user research,
and is something people at all levels of an organization can engage in.
CDC also obtained OMB approval for a generic clearance to support the
collection of information from stakeholders and customers, utilizing I-
Catalyst program principles and methodology (CDC I-Catalyst Program,
OMB Control No. 0920-1158, Exp. date 1/31/2020).
The goal of the I-Catalyst program is to help CDC employees test
and explore their ideas through a discovery, ideation, and prototyping
process. I-Catalyst offers a process for defining problems and
developing strategies to solutions that will help improve the quality
and efficiency of innovation efforts and, as a result, overall
performance. Through the I-Catalyst Program, teams work to define and
articulate their problem space to find effective solutions and CDC
programs receive consultation from OTI staff to implement the I-
Catalyst process with specific projects. Participating teams will go
through a hypothesis-testing, scientific method of discovery to gather
important insights and identify issues associated with their projects.
Teams are forced ``out of the classroom'' to conduct interviews, study
customer/stakeholder needs, collect feedback, and find partnership
opportunities. It is expected that participants will gain the ability
to evaluate and translate their insights into solutions.
The I-Catalyst process provides CDC staff with real-world, hands-on
entrepreneurship training and consultation from OTI staff. Through I-
Catalyst, CDC staff make hypotheses about how the world works, and then
test them by getting out of the building and talking to customers and/
or stakeholders. Only conversations with potential customers/
stakeholders can provide the facts from which hypotheses are proven or
disproven about whether a solution (whether a product, process, etc.)
creates value for the intended beneficiaries. Participants have to go
out into the world and learn by doing. I-Catalyst methods engage
customers/stakeholders in a process that will identify what they most
value and need, and source solutions that will have high levels of
efficacy and user acceptability.
The majority of data will be obtained through on-site, unstructured
interviews with individuals who represent the customers or stakeholders
CDC teams are attempting to serve or benefit. CDC may also collect
information through telephone interviews, questionnaires, or web-based
surveys. With each CDC program project, teams will interview their
customers/stakeholders with a burden per response ranging from 20-60
minutes (an average of 30 minutes). Each team will interview
approximately 25 respondents. With 10-20 teams participating annually
and CDC program consultations, approximately 500 respondents will be
interviewed. Data to be collected includes information regarding needs,
values, and barriers, and facilitators to potential solutions.
CDC expects that teams participating in the I-Catalyst process and
OTI consultations will be empowered to implement innovative strategies
and solutions that create value for a set of beneficiaries. The
ultimate goal is to give CDC staff skills to successfully transfer
knowledge into value-based solutions that benefit society and broaden
the agency's impact.
In this Revision request, CDC seeks approval for minor changes to
the I-Catalyst generic clearance. The number of burden hours will
decrease based on participation in the I-Catalyst training program
during the period 2017-2019. However, through related technical
assistance provided by OTI to CDC/ATSDR programs, CDC has identified
additional opportunities for information collection compatible with I-
Catalyst goals and methods. During the next three-year period CDC
anticipates utilization of the I-Catalyst generic clearance by previous
participants in the I-Catalyst training program, as well as other CDC
programs implementing customer discovery projects. The title of the
clearance is being updated to reflect its use by additional CDC/ATSDR
project teams approved by OTI. The I-Catalyst clearance will continue
to be used for information collections necessary to explore the needs
and preferences of specific stakeholder groups, and to facilitate and
improve the acceptance and usability of CDC products, programs, and
technologies. All projects submitted to OMB for approval under the I-
Catalyst generic
[[Page 57437]]
clearance will be consistent with CDC/OTI goals for promoting
scientific innovation, customer engagement, and entrepreneurship in
public health.
OMB approval is requested for three years. Individual projects must
be approved by CDC's OTI before they are submitted to OMB for final
review and approval. CDC estimates the estimated annual burden hours to
be 250. Participation is voluntary, and there are no costs to
respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
External Partners, Interview 500 1 30/60 250
Stakeholders, or Customers. Guides,
Questionnaires,
and Surveys.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 250
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-23366 Filed 10-24-19; 8:45 am]
BILLING CODE 4163-18-P